305 related articles for article (PubMed ID: 25869677)
21. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
[TBL] [Abstract][Full Text] [Related]
22. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
[TBL] [Abstract][Full Text] [Related]
23. Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.
Slone S; Anthony SR; Wu X; Benoit JB; Aube J; Xu L; Tranter M
Cell Signal; 2016 Nov; 28(11):1735-41. PubMed ID: 27521603
[TBL] [Abstract][Full Text] [Related]
24. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056
[TBL] [Abstract][Full Text] [Related]
25. Tissue distribution and functional expression of a cDNA encoding a novel mixed lineage kinase.
Bloem LJ; Pickard TR; Acton S; Donoghue M; Beavis RC; Knierman MD; Wang X
J Mol Cell Cardiol; 2001 Sep; 33(9):1739-50. PubMed ID: 11549352
[TBL] [Abstract][Full Text] [Related]
26. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
27. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N
Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762
[TBL] [Abstract][Full Text] [Related]
28. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
El Jamali A; Freund C; Rechner C; Scheidereit C; Dietz R; Bergmann MW
FASEB J; 2004 Jul; 18(10):1096-8. PubMed ID: 15155564
[TBL] [Abstract][Full Text] [Related]
29. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.
Liu Q; Sargent MA; York AJ; Molkentin JD
Circ Res; 2009 Nov; 105(11):1110-7. PubMed ID: 19815822
[TBL] [Abstract][Full Text] [Related]
30. Multiprotein bridging factor 1 cooperates with c-Jun and is necessary for cardiac hypertrophy in vitro.
Busk PK; Wulf-Andersen L; Strøm CC; Enevoldsen M; Thirstrup K; Haunsø S; Sheikh SP
Exp Cell Res; 2003 May; 286(1):102-14. PubMed ID: 12729799
[TBL] [Abstract][Full Text] [Related]
31. The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.
Rey C; Faustin B; Mahouche I; Ruggieri R; Brulard C; Ichas F; Soubeyran I; Lartigue L; De Giorgi F
Oncogene; 2016 Jun; 35(24):3190-200. PubMed ID: 26522728
[TBL] [Abstract][Full Text] [Related]
32. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
[TBL] [Abstract][Full Text] [Related]
33. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
Ma Q; Liu Y; Chen L
Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
[TBL] [Abstract][Full Text] [Related]
34. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
35. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
[TBL] [Abstract][Full Text] [Related]
36. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
37. M-CAT element mediates mechanical stretch-activated transcription of B-type natriuretic peptide via ERK activation.
Koivisto E; Karkkola L; Majalahti T; Aro J; Tokola H; Kerkelä R; Ruskoaho H
Can J Physiol Pharmacol; 2011 Aug; 89(8):539-50. PubMed ID: 21812548
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.
Ge Y; Pan S; Guan D; Yin H; Fan Y; Liu J; Zhang S; Zhang H; Feng L; Wang Y; Xu R; Yin JQ
Biochim Biophys Acta; 2013 Jan; 1832(1):1-10. PubMed ID: 23000971
[TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
